The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2022 | The role of PET/CT in multiple myeloma
Jakob Nordberg Nørgaard
• 11 Jun 2022
Jakob Nordberg Nørgaard, PhD, Oslo University Hospital, Oslo, Norway, outlines the role of PET/CT in the diagnosis and management of multiple myeloma. PET/CT is a very sensitive technique used for the diagnosis of extramedullary disease and osteolytic lesions, as well as for risk stratification and response assessment. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.
